Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01063114 · ClinicalTrials.gov registry record · NA
Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma
A NA study of Brain Tumor and Medulloblastoma, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 2
- Study locations
NCT01063114 is a NA study of Brain Tumor and Medulloblastoma that has completed, run by Massachusetts General Hospital. The registered enrollment target is 90 participants, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01063114, a NA study of Brain Tumor and Medulloblastoma, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
There are two types of external radiation treatments (proton beam and photon beam). As part of the participant's treatment, they will receive radiation to the entire central nervous system (CNS); this is known as craniospinal irradiation (CSI). In the past, photon radiation therapy has been used for CSI. In this study we will be examining the effects of proton beam radiation therapy. Studies have suggested that this kind of radiation can cause less damage to normal tissue than photon radiation therapy. The physical characteristics of proton beam radiation let the doctor safely deliver the amount of radiation delivered to the tumor that is normally delivered through standard therapy but spare more normal tissue in the process.
Conditions Studied
Interventions
- RADIATION proton beam radiation
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2010-04-08 |
| Est. Completion | 2021-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01063114
The ClinicalTrials.gov registry entry for NCT01063114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (68% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which proton beam radiation is the first listed.
NCT01063114 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Texas.
Frequently Asked Questions
What is clinical trial NCT01063114 about?
NCT01063114 is a clinical study titled "Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma". There are two types of external radiation treatments (proton beam and photon beam). As part of the participant's treatment, they will receive radiation to the entire central nervous system (CNS); this is known as craniospinal irradiation (CSI). In the past, photon radiation therapy has been used for...
What is the current status of trial NCT01063114?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2010-04-08. Estimated completion is 2021-11.
What conditions does trial NCT01063114 study?
This clinical trial studies the following conditions: Brain Tumor, Medulloblastoma, Pineoblastoma.
What interventions are being tested in trial NCT01063114?
The interventions under investigation include: proton beam radiation (RADIATION).
Who is sponsoring clinical trial NCT01063114?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01063114 being conducted?
This trial has 2 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors
RECRUITING · NA
-
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
RECRUITING · NA
-
Ommaya Reservoir Placement for Brain Tumor Biomarker Access
RECRUITING · NA
-
Mapping of Human Cognition
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.